Genmab - Stock Price History | GMAB

Historical daily share price chart and data for Genmab since 2021 adjusted for splits. The latest closing stock price for Genmab as of October 27, 2021 is 45.20.
  • The all-time high Genmab stock closing price was 48.72 on September 03, 2021.
  • The Genmab 52-week high stock price is 49.07, which is 8.6% above the current share price.
  • The Genmab 52-week low stock price is 30.10, which is 33.4% below the current share price.
  • The average Genmab stock price for the last 52 weeks is 40.24.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Genmab Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 30.8508 22.3000 40.7600 17.1500 40.6600 82.09%
2019 20.8930 18.1000 24.1400 18.0200 22.3300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $29.992B $1.549B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86